Survival and Cost-Effectiveness of Trabectedin Compared to Ifosfamide Monotherapy in Advanced Soft Tissue Sarcoma Patients

Trabectedin and ifosfamide are among the few cytostatic agents active in advanced soft tissue sarcomas (STSs). Trabectedin is most potent against so-called L-sarcomas (leiomyosarcoma and liposarcoma). The survival gain and cost-effectiveness of these agents in a second-line setting were analysed in...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Sarcoma
Main Authors: Verboom, Michiel C., Gelderblom, Hans, Kerst, J. Martijn, Steeghs, Neeltje, Reyners, Anna K. L., Sleijfer, Stefan, van der Graaf, Winette T. A., van den Hout, Wilbert B.
Format: Artigo
Jezik:Inglês
Izdano: Hindawi 2019
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6589299/
https://ncbi.nlm.nih.gov/pubmed/31281207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/3234205
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki